Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 11.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 27.50
  • 52 Week Low: 4.75
  • Currency: UK Pounds
  • Shares Issued: 170.32m
  • Volume: 17,076
  • Market Cap: £18.74m
  • RiskGrade: 429

Latest ShareCast News

Verici Dx completes analytical validation on two assays

By Josh White

Date: Tuesday 15 Feb 2022

(Sharecast News) - Clinical diagnostics developer Verici Dx announced on Tuesday that its two lead in-vitro diagnostic assays, 'Clarava' and 'Tuteva', had completed analytical validation under the CLIA requirements, meeting criteria for robust assay performance.

Verici Dx enters collaboration with Nasdaq-listed Illumina

By Josh White

Date: Wednesday 05 Jan 2022

(Sharecast News) - Organ transplant clinical diagnosis developer Verici Dx announced a collaboration with Nasdaq-listed Illumina on Wednesday, to expedite the operational launch of data analysis processing and the predictive artificial intelligence component of its products using early access to Illumina's new software platform ICA.

Verici granted 'fundamental' codes for tests in US market

By Josh White

Date: Tuesday 04 Jan 2022

(Sharecast News) - Organ transplant diagnostics company Verici Dx has been granted 'CPT' proprietary laboratory analyses (PLA) codes for both its 'Clarava' and 'Tuteva' tests by the American Medical Association (AMA), it announced on Tuesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 11.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 27.50
52 Week Low 4.75
Volume 17,076
Shares Issued 170.32m
Market Cap £18.74m
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.73% below the market average24.73% below the market average24.73% below the market average24.73% below the market average24.73% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average
Price Trend
71.77% below the market average71.77% below the market average71.77% below the market average71.77% below the market average71.77% below the market average
54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average54.1% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 26-May-2023

Time Volume / Share Price
15:29 3,576 @ 10.68p
09:12 13,500 @ 11.37p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page